BL Barber

626 total citations
15 papers, 482 citations indexed

About

BL Barber is a scholar working on Oncology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, BL Barber has authored 15 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Physiology and 4 papers in Psychiatry and Mental health. Recurrent topics in BL Barber's work include Schizophrenia research and treatment (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Asthma and respiratory diseases (3 papers). BL Barber is often cited by papers focused on Schizophrenia research and treatment (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Asthma and respiratory diseases (3 papers). BL Barber collaborates with scholars based in United States, France and Italy. BL Barber's co-authors include Nancy C. Santanello, Beth C. Seidenberg, Theodore F. Reiss, E. F. Juniper, Rhys Pockett, Daniel Castellano, Phil McEwan, Alan Oglesby, Karen Chung and Robert S. Epstein and has published in prestigious journals such as European Respiratory Journal, Schizophrenia Research and Quality of Life Research.

In The Last Decade

BL Barber

14 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
BL Barber United States	6	279	268	89	71	59	15	482
Eve Denton Australia	10	301 1.1×	297 1.1×	48 0.5×	37 0.5×	54 0.9×	27	503
David J. Valacer United States	8	326 1.2×	267 1.0×	38 0.4×	18 0.3×	46 0.8×	15	485
Vivian Chia‐Rong Hsieh Taiwan	10	69 0.2×	45 0.2×	39 0.4×	48 0.7×	45 0.8×	36	354
Yong‐Chen Chen Taiwan	11	70 0.3×	64 0.2×	80 0.9×	83 1.2×	7 0.1×	41	362
Rachel Bergman United States	4	198 0.7×	168 0.6×	25 0.3×	28 0.4×	29 0.5×	5	351
Hubert Méchin France	8	325 1.2×	101 0.4×	15 0.2×	54 0.8×	327 5.5×	17	504
Manon G. A. van den Berg Netherlands	11	303 1.1×	144 0.5×	97 1.1×	75 1.1×	40 0.7×	21	546
Peter Dale United Kingdom	11	245 0.9×	202 0.8×	24 0.3×	22 0.3×	71 1.2×	24	412
Beth Cronin United States	8	112 0.4×	59 0.2×	33 0.4×	99 1.4×	78 1.3×	26	420
Daniele Civello Germany	9	83 0.3×	75 0.3×	33 0.4×	18 0.3×	10 0.2×	13	341

Countries citing papers authored by BL Barber

Since Specialization

Citations

This map shows the geographic impact of BL Barber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by BL Barber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BL Barber more than expected).

Fields of papers citing papers by BL Barber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by BL Barber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by BL Barber. The network helps show where BL Barber may publish in the future.

Co-authorship network of co-authors of BL Barber

This figure shows the co-authorship network connecting the top 25 collaborators of BL Barber. A scholar is included among the top collaborators of BL Barber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with BL Barber. BL Barber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ma, Qi, et al.. (2016). Prevalence Of Autoimmune Comorbidities In Patients With Metastatic Melanoma In The United States. Value in Health. 19(3). A135–A135. 1 indexed citations

Kreuzer, Karl‐Anton, et al.. (2015). Hospitalisations Among Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) Receiving Chemotherapy in Germany: A Retrospective Chart Review. Value in Health. 18(7). A443–A443. 4 indexed citations

Ma, Qi, et al.. (2015). Current Treatment Patterns In Patients With Metastatic Melanoma: A Retrospective Claims Database Analysis In The United States (Us). Value in Health. 18(7). A492–A492. 3 indexed citations

Dombret, Hervé, Xavier Thomas, Patrice Chevallier, et al.. (2015). Healthcare Burden and Economic Cost of Hospitalisation During Chemotherapy for Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) in France. Value in Health. 18(7). A443–A443. 1 indexed citations

Pagano, Livio, et al.. (2015). Retrospective Chart Review of Hospitalisations During Chemotherapy for Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) In Italy. Value in Health. 18(7). A443–A443. 4 indexed citations

Zhao, Zhen, et al.. (2012). Cardiovascular comorbidities among patients with metastatic colorectal cancer. 1(1). 4–4. 2 indexed citations

Pockett, Rhys, Daniel Castellano, Phil McEwan, et al.. (2009). The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain. European Journal of Cancer Care. 19(6). 755–760. 97 indexed citations

Kinon, BJ, et al.. (2003). Acute response to olanzapine predicts continued improvement in schizophrenia. Schizophrenia Research. 60(1). 308–308. 5 indexed citations

Kinon, BJ, et al.. (2001). PMH2: IMPROVEMENT IN QUALITY OF LIFE AND DEPRESSIVE SYMPTOMS IN SCHIZOPHRENIC PATIENTS IS ASSOCIATED WITH ROBUST ACUTE TREATMENT RESPONSE OF OLANZAPINE VERSUS HALOPERIDOL. Value in Health. 4(6). 451–451. 3 indexed citations

10.

Kinon, BJ, et al.. (2001). PMH1: RIGOROUS CRITERIA FOR TREATMENT RESPONSE DIFFERENTIATED EFFICACY OF OLANZAPINE VERSUS HALOPERIDOL IN PATIENTS WITH SCHIZOPHRENIA. Value in Health. 4(6). 450–451. 2 indexed citations

11.

Johnsrud, Michael, et al.. (2001). PMH33: OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA: A COMPARISON OF COSTS AMONG TEXAS MEDICAID PATIENTS. Value in Health. 4(2). 151–152. 8 indexed citations

12.

Barber, BL, et al.. (2000). PMH1: RECENT TRENDS IN THE COST OF CARE FOR PATIENTS WITH SCHIZOPHRENIA. Value in Health. 3(2). 77–77. 1 indexed citations

13.

Santanello, Nancy C., et al.. (1999). What are minimal important changes for asthma measures in a clinical trial?. European Respiratory Journal. 14(1). 23–23. 207 indexed citations

14.

Barber, BL, et al.. (1997). Measurement characteristics of two asthma symptom diary scales for use in clinical trials. European Respiratory Journal. 10(3). 646–651. 111 indexed citations

15.

Barber, BL, Nancy C. Santanello, & Robert S. Epstein. (1996). Impact of the global on patient perceivable change in an asthma specific QOL questionnaire. Quality of Life Research. 5(1). 117–122. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact